Daratumumab: Solution concentrate for I.V infusion 100 mg in 5 mL, Solution concentrate for I.V infusion 400 mg in 20 mL; Darzalex® Page last updated: 20 March 2020 Public Summary Document (PSD) November 2019 PBAC Meeting - (PDF 706KB) Public Summary Document (PSD) November 2019 PBAC Meeting - (Word 181KB)